The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism

Introduction: A number of anti-diabetic treatments have been favored during the continuing spread of the current SARS-CoV-2 pandemic. Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are a group of antidiabetic drugs, the glucose-reducing effect of which is founded on augmenting glucose-dependen...

ver descrição completa

Detalhes bibliográficos
Autor principal: Banerjee, Yajnavalka (author)
Outros Autores: Stoian, Anca Pantea (author), Silva-Nunes, José (author), Sonmez, Alper (author), Rizvi, Ali A. (author), Janez, Andrej (author), Rizzo, Manfredi (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
COVID-19
SARS-CoV-2
GLP-1RA
Coronavirus
Diabetes
Pandemic
Texto completo:http://hdl.handle.net/10400.21/13684
País:Portugal
Oai:oai:repositorio.ipl.pt:10400.21/13684

Texto Completo

http://hdl.handle.net/10400.21/13684

Registros relacionados